The National Center for Child Health and Development said that the survival rate was more than doubled when "fetal treatment" was performed to treat a foetation whose lungs did not grow normally due to a congenital illness while in the stomach. Announced by an international group of participants.

"Fetal treatment" is a state-of-the-art medical treatment that treats a foetation in which a serious illness is found while it is in the mother's tummy.

The National Center for Growth Medicine participated in a clinical trial of fetal treatment conducted by an international group for a disease called "congenital diaphragmatic hernia" in which the lungs do not grow normally, and by March last year, especially overseas. A total of 40 severely ill fetuses were treated.

This treatment involves inserting a thin tube through the mouth of the foetation in the mother's tummy and inflating a balloon called a balloon in the trachea to prevent the fluid in the lungs from leaking. You will need it.

According to the group, the survival rate in the second half of life was 15% with conventional treatment, but the survival rate was 40% in babies treated with fetal treatment, which was confirmed to be more than doubled.

Haruhiko Sago, Deputy Director of the National Center for Child Health and Development, said, "The number of lives that can be saved by fetal treatment will surely increase. We would like to establish a system that allows patients to receive treatment with peace of mind."